HEFT EMCAST UPPER GI BLEEDS; WHAT’S YOUR THRESHOLD?

Slides:



Advertisements
Similar presentations
AF and the New Oral Anti-Coagulants
Advertisements

UPPER GI BLEEDS.  Bleeding from a gastrointestinal source proximal to the ligament of Treitz which occurs at the duodeno- jejunal flexture. Definition.
A Randomized Trial of Protocol-Based Care for Early Septic Shock Andrea Caballero, MD January 15, 2015 LSU Journal Club The ProCESS Investigators. N Engl.
Pablo M. Bedano M.D. Community Regional Cancer Care.
UPPER GASTROINTESTINAL BLEEDING
THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY (ACCORD)
TXA in trauma patients: who should we treat and when?
Clinical Trial Results. org Tilman B. Drüeke, M.D.; Francesco Locatelli, M.D.; Naomi Clyne, M.D.; Kai-Uwe Eckardt, M.D.; Iain C. Macdougall, M.D.; Dimitrios.
THE TRISS TRIAL Holst, L et al. Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock. New England Journal of Medicine October 9, 2014.
Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Jiang He, Yonghong Zhang, Tan Xu, Weijun Tong, Shaoyan Zhang,
Overly concerning and falsely reassuring?? FRAMINGHAM RISK FACTORS IN THE ED.
Single Unit Transfusion Guideline for Red Blood Cell Transfusion
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
0902CZR01NL537SS0901 RENAAL Altering the Course of Renal Disease in Hypertensive Patients with Type 2 Diabetes and Nephropathy with the A II Antagonist.
VBWG OASIS-5 The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
Intensive versus Conventional Glucose Control in Critical Ill Patients N Engl J Med 2009; 360: 雙和醫院 劉慧萍藥師.
COLLAPSE ? CAUSE. WHY IS THIS AN IMPORTANT TOPIC TO MASTER? One of the great skills in EM is the ability to risk stratify patients accurately and to formulate.
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
Irbesartan Diabetic Nephropathy Trial (IDNT) Collaborative Study Group N Eng J Med 345: , 2001 Edmund J. Lewis, M.D. Muehrcke Family Professor of.
Blatchford score is a useful tool for predicting the need for intervention in cancer patients with upper gastrointestinal bleeding. Ahn S, Lim KS, Lee.
The TRial Of Preventing HYpertension (TROPHY) TROPHY.
Monthly Journal article review: Vimmi Kang PGY 2
Jamaica Conference 3/30/15 Sariah Khormaee TRANEXAMIC ACID (TXA): The promise of a nearly perfect drug for the bleeding trauma patient.
Dick de Zeeuw Department of Clinical Pharmacology University Medical Center Groningen The Netherlands Albuminuria; a tool for measuring non-blood pressure.
Pai JK et al. N Engl J Med 2004; 351: Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP
Advantages of colonoscopy in acute lower GI bleeding Charles Sullivan 28/08/13.
Jim Hoehns, Pharm.D.. Lancet 2013;382: Albers G et al. Chest. 2001; 119 (suppl): 300S. Ischemic stroke 85% Hemorrhagic stroke 15% Other 5% Cryptogenic.
December 20, 2013 Salman Khalid PGY-3 Eric Loman PGY-2 CRITICAL CARE M&M.
RITA-3 ESC 4 th September 2005 The impact of underlying risk and gender on the benefit of early intervention in non-ST elevation acute coronary syndrome.
Background There are 12 different types of medications to lower blood sugar levels in patients with type 2 diabetes. It is widely agreed upon that metformin.
OFEV ® (nintedanib) TOMORROW trial results Last updated These slides are provided by Boehringer Ingelheim for medical to medical education only.
Preoperative Hemoglobin A1c and the Occurrence of Atrial Fibrillation Following On-pump Coronary Artery Bypass surgery in Type-2 Diabetic Patients Akbar.
Small Bowel Toxicity of Nonselective NSAIDs Revealed by Capsule Endoscopy: Results From a Pivotal Clinical Trial Glenn M. Eisen, M.D., M.P.H. Associate.
Enrollment and Outcomes Duckworth W, et al. N Engl J Med 2009;360:
TREATMENT OF ANEMIA WITH DARBEPOETIN ALFA IN SYSTOLIC HEART FAILURE Karl Swedberg, M.D., Ph.D., James B. Young, M.D., Inder S. Anand, M.D., Sunfa Cheng,
A pilot randomized controlled trial Registry #: NCT
Duration Safety and Efficacy of Bivalirudin in patients undergoing PCI: The impact of duration of infusion in ACUITY trial Dr. David Cox Lehigh Valley.
Predicting Mortality in Non-Variceal Upper Gastrointestinal Bleeders: Validation of the Italian PNED Score and Prospective Comparison With the Rockall.
Edward S. Huang, MD, MPH, Sundip Karsan, MD, MPH, Fasiha Kanwal, MD, MSHS, Inder Singh, MD, Marc Makhani, MD, Brennan M. Spiegel, MD, MSHS Boston, Massachusetts;
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Coronary Intervention Complications.
The impact of hyperacute blood pressure lowering on the early clinical outcome following intracerebral hemorrhage Ryo Itabashia, Kazunori Toyodaa,b, Masahiro.
Introduction Upper gastrointestinal bleeding (UGIB)
Nephrology Journal Club The SPRINT Trial Parker Gregg
a cautionary note from SPRINT
a cautionary note from SPRINT
The SPRINT Research Group
Approach to gastrointestinal bleeding
Matt Warren. Gastroenterology North Tyneside Hospital
Hypertension November 2016
Hypertension in the Post SPRINT era
Copyright © 2011 American Medical Association. All rights reserved.
NYHA III* or IV heart failure ACE-I + loop diuretic ± digoxn
Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.
Acute upper gastrointestinal Bleeding
Consultant CPD, November 23rd 2016
GASTROENTEROLOGY 2009;137:892–901 R2. 정 회 훈.
Dr gavidel Journal club govaresh DR GAVIDEL
TNT: Baseline and final LDL cholesterol levels
Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic
Systolic Blood Pressure Intervention Trial (SPRINT)
Adjusted mortality risk
John Grant-Casey & Sarah Hearnshaw
Risk for BMI outcome (%)
PPI prophylaxis for GI bleeding in ICU
Inclusion Criteria for Patients with Multiple Atherothrombotic Risk Factors and for Those with Established Cardiovascular Disease Deepak L.Bhatt, et al,
Hypertension November 2016
ROC plots of the association of this score, the Rockall Score and the Blatchford Score with RET (a), death (b), and the combined Blatchford outcome (c)
Kaplan–Meier plots of 5 and 12-year all cause (A and C, respectively) and cardiovascular mortality (B and D, respectively) with number of participants.
Increase of physical activity over time associated with lower HF risk
Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.
Presentation transcript:

HEFT EMCAST UPPER GI BLEEDS; WHAT’S YOUR THRESHOLD?

GUIDELINES The British Society of Gastroenterology guidelines on Acute GI bleeding recommends the use of the Blatchford Score for Risk stratifying patients; Score of 0 equates to low risk Score of ≥1 equates to high risk

THE BLATCHFORD SCORE Systolic blood pressure Urea Comrobidities/other markers Haemoglobin

Risk markerAssociated score Systolic BP (mmHg) < 903 Urea ≥6.5 <8.02 ≥8.0 <10.03 ≥10.0 <25.04 ≥256 Comorbidities/other markers Pulse ≥ 100 bpm1 Presenting with malaena1 Presenting with syncope1 Hepatic disease2 Cardiac failure2 Haemoglobin (g/dl) men ≥12.0 <13.01 ≥10.0 <12.03 <10.06 Haemoglobin (g/dl) women ≥10.0 <12.01 <10.06

THE PAPER Transfusion strategies for acute upper gastrointestinal bleeding N Engl J Med. 2013

SCORE Blatchford score of 0 equates to low risk Approx 25% of ED patients are low risk British society for gastroenterology recommends; ‘for those with significant bleeding, early endoscopy plays a central role in management’ SIGN guideline UGIB - recommends endoscopy within 24 hours of presentation SIGN guideline UGIB

INCLUSION CRITERIA >18 years of age Experiencing either haematemesis (NG bloody aspirate), malaena or both as confirmed by hospital staff

EXCLUSION CRITERIA Patients declining to undergo transfusion Masive exsanguinating bleeding ACS Lower GI bleeding Rockall score of 0 with an HB of > 12 g/dl And others…….

INTERVENTION Restrictive strategy (RS) Threshold for transfusion was 7 g per dl Target of transfusion 7 – 9 g per dl Liberal-strategy (LS) Threshold for transfusion 9 g per dl Target range for transfusion of 9-11 g per dl

OUTCOMES Primary mortality within 45 days Secondary Further bleeding In hospital complications

RESULTS Primary outcome – mortality at 45 days RS 5% LS 9% p value 0.02

RESULTS Secondary outcomes Rate of further bleeding (after adjustment for baseline risk factors) lower in the RS Hazard ratio % CI Complication rate RS 40% LS 48%

REFERNECES British Society of Gastroenterology guidelines on Acute GI bleeding Villanueva, C., Colomo, A., Bosch, A., Concepción, M., Hernandez-Gea, V., Aracil, C. et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013; 368: 11–21